Treatment of Real-World HCV Genotype 2-Infected Japanese Patients with Sofosbuvir plus Ribavirin

The aim of this study was to characterize the treatment response and tolerability of sofosbuvir plus ribavirin therapies in Japanese patients infected with hepatitis C virus (HCV) genotype (GT)-2. This retrospective study analyzed 114 Japanese HCV GT-2 patients treated for 12 weeks with 400 mg of so...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Biology (Basel)
Main Authors: Kanda, Tatsuo, Nakamura, Masato, Yasui, Shin, Haga, Yuki, Tawada, Akinobu, Suzuki, Eiichiro, Ooka, Yoshihiko, Takahashi, Koji, Sasaki, Reina, Wu, Shuang, Nakamoto, Shingo, Arai, Makoto, Imazeki, Fumio, Yokosuka, Osamu
Formato: Artigo
Idioma:Inglês
Publicado: MDPI 2017
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5485477/
https://ncbi.nlm.nih.gov/pubmed/28486403
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biology6020030
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares